Table 1.
Variable* | Normal TCD measurements, no evidence of silent cerebral infarct MRI (n=353) | Normal TCD measurements, evidence of silent cerebral infarct (n=68) | P Value* |
---|---|---|---|
Age at registration | 8.9 (2.4) | 9.1 (2.6) | 0.437 |
Sex, Male (%) | 49.6 | 54.4 | 0.465 |
Systolic blood pressure (n=416) | 107.5 (11.8) | 110.6 (10.5) | 0.044 |
Steady state hemoglobin | 8.3 (1.2) | 7.9 (1.0) | 0.006 |
Reticulocytes (%) (n=418) | 11.6 (5.6) | 14.3 (6.3) | <0.001 |
Hydroxyurea use before end of follow-up (%) | 25.2 | 23.5 | 0.769 |
Chronic transfusion before end of follow-up (%) | 4.8 | 7.4 | 0.375# |
Follow-up time until event, end-of study, or chronic transfusion, years | 3.6 (1.3) | 3.4 (1.5) | 0.270 |
New neurological event (stroke, seizure or TIA) (%) | 1.7 | 5.9 | 0.061# |
Incidence rate, new neurological events (events/100 patient-years), 95% confidence interval | 0.47 (0.17 – 1.02) | 1.71 (0.46 – 4.37) | 0.065§ |
Mean and standard deviation or chi-square test unless otherwise noted
Fisher’s exact test
Mid-p exact test